2017
DOI: 10.15406/emij.2017.05.00120
|View full text |Cite
|
Sign up to set email alerts
|

The Estrogen and Progesterone Receptors in Endometrial Carcinoma - An Update

Abstract: Immunohistochemistry of estrogen (ER) and progesterone (PR) receptors in breast cancer is an established method of predicting responsiveness to hormonal treatment and calculating the prognosis and disease free survival rates. However the utility of immunohistochemistry of ER and PR in endometrial cancer (EC), another hormone dependent neoplasia has not yet been well defined and is not a routine in treatment algorithms. Their changing levels in various stages of menstrual cycle and action by alteration of genes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 53 publications
0
2
0
Order By: Relevance
“…In a study of breast cancer cells, they investigated the effect of DHT on progesterone receptors [ 45 ]. Progesterone receptor A (PR-A) and progesterone receptor B (PR-B) have antagonistic effects in endometrium, since PR-A modulates the anti-proliferative effects of progesterone in the uterus and PR-B in the absence of PR-A leads to cell growth [ 46 ]. In the mentioned study, they came to the conclusion that DHT had some transcriptional activity through PR-B, but not through PR-A [ 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…In a study of breast cancer cells, they investigated the effect of DHT on progesterone receptors [ 45 ]. Progesterone receptor A (PR-A) and progesterone receptor B (PR-B) have antagonistic effects in endometrium, since PR-A modulates the anti-proliferative effects of progesterone in the uterus and PR-B in the absence of PR-A leads to cell growth [ 46 ]. In the mentioned study, they came to the conclusion that DHT had some transcriptional activity through PR-B, but not through PR-A [ 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…Progestins act as powerful antiestrogens by helping to convert estradiol to estrone sulfate that rapidly gets cleared from the body. Furthermore, progestins antagonize estrogen action by inhibiting estrogen's induction of its receptors 18 . This hypoestrogenic state is thought to regress AVM.…”
Section: Discussionmentioning
confidence: 99%